| Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study J Lammer, K Malagari, T Vogl, F Pilleul, A Denys, A Watkinson, M Pitton, ... Cardiovascular and interventional radiology 33, 41-52, 2010 | 1869 | 2010 |
| Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update M Ahmed, L Solbiati, CL Brace, DJ Breen, MR Callstrom, JW Charboneau, ... Radiology 273 (1), 241-260, 2014 | 1532 | 2014 |
| EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma EO for Research, European Association for the Study of the Liver Journal of hepatology 56 (4), 908-943, 2012 | 1145 | 2012 |
| Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ A Cervantes, R Adam, S Roselló, D Arnold, N Normanno, J Taïeb, ... Annals of Oncology 34 (1), 10-32, 2023 | 916 | 2023 |
| Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data R Lencioni, T de Baere, MC Soulen, WS Rilling, JFH Geschwind Hepatology 64 (1), 106-116, 2016 | 786 | 2016 |
| High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial C Massard, S Michiels, C Ferté, MC Le Deley, L Lacroix, A Hollebecque, ... Cancer discovery 7 (6), 586-595, 2017 | 734 | 2017 |
| Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma JM Llovet, T De Baere, L Kulik, PK Haber, TF Greten, T Meyer, R Lencioni Nature reviews Gastroenterology & hepatology 18 (5), 293-313, 2021 | 717 | 2021 |
| Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study MP Goetz, MR Callstrom, JW Charboneau, MA Farrell, TP Maus, TJ Welch, ... Journal of Clinical Oncology 22 (2), 300-306, 2004 | 706 | 2004 |
| Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence JL Raoul, A Forner, L Bolondi, TT Cheung, R Kloeckner, T de Baere Cancer treatment reviews 72, 28-36, 2019 | 584 | 2019 |
| Adverse events during radiofrequency treatment of 582 hepatic tumors T de Baère, O Risse, V Kuoch, C Dromain, C Sengel, T Smayra, MGE Din, ... American Journal of Roentgenology 181 (3), 695-700, 2003 | 579 | 2003 |
| Guidelines for patient radiation dose management MS Stecker, S Balter, RB Towbin, DL Miller, E Vañó, G Bartal, JF Angle, ... Journal of Vascular and Interventional Radiology 20 (7), S263-S273, 2009 | 532 | 2009 |
| Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year T de Baere, D Elias, C Dromain, MGE Din, V Kuoch, M Ducreux, V Boige, ... American Journal of Roentgenology 175 (6), 1619-1625, 2000 | 526 | 2000 |
| Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging C Dromain, T de Baere, J Lumbroso, H Caillet, A Laplanche, V Boige, ... Journal of clinical oncology 23 (1), 70-78, 2005 | 494 | 2005 |
| Occupational radiation protection in interventional radiology: a joint guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of … DL Miller, E Vañó, G Bartal, S Balter, R Dixon, R Padovani, B Schueler, ... Cardiovascular and interventional radiology 33, 230-239, 2010 | 483 | 2010 |
| Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised … E Garin, L Tselikas, B Guiu, J Chalaye, J Edeline, T de Baere, E Assenat, ... The lancet Gastroenterology & hepatology 6 (1), 17-29, 2021 | 470 | 2021 |
| During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma D Elias, T De Baere, A Roche, M Ducreux, J Leclere, P Lasser British Journal of Surgery 86 (6), 784-788, 1999 | 446 | 1999 |
| NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In … S Bonvalot, PL Rutkowski, J Thariat, S Carrère, A Ducassou, MP Sunyach, ... The Lancet Oncology 20 (8), 1148-1159, 2019 | 421 | 2019 |
| Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up C Dromain, T de Baere, D Elias, V Kuoch, M Ducreux, V Boige, P Petrow, ... Radiology 223 (1), 255-262, 2002 | 415 | 2002 |
| Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases T De Baère, A Aupérin, F Deschamps, P Chevallier, Y Gaubert, V Boige, ... Annals of oncology 26 (5), 987-991, 2015 | 393 | 2015 |
| Are G3 ENETS neuroendocrine neoplasms heterogeneous FL Vélayoudom-Céphise, P Duvillard, L Foucan, J Hadoux, CN Chougnet, ... Endocr Relat Cancer 20 (5), 649-57, 2013 | 392 | 2013 |
Michel DucreuxUniversité Paris-Saclay, Gustave Roussy確認したメール アドレス: gustaveroussy.fr
